Idelalisib is effective in patients with high-risk follicular lymphoma and early relapse after initial chemoimmunotherapy

Ajay K. Gopal, Brad S. Kahl, Christopher R. Flowers, Peter Martin, Stephen M. Ansell, Esteban Abella-Dominicis, Brian Koh, Wei Ye, Paul M. Barr, Gilles A. Salles, Jonathan W. Friedberg

Research output: Contribution to journalReview articlepeer-review

63 Scopus citations
Original languageEnglish
Pages (from-to)3037-3039
Number of pages3
JournalBlood
Volume129
Issue number22
DOIs
StatePublished - Jun 1 2017

Cite this